Wild, C. (2007): [Growth hormones: Possible late effects]. HTA-Newsletter 54: pp. 3-4.
Preview |
PDF (HTA-Newsletter 54)
- Sie müssen einen PDF-Viewer auf Ihrem PC installiert haben wie z. B. GSview, Xpdf oder Adobe Acrobat Reader
354kB |
Official URL: http://hta.lbg.ac.at/de/newsletter_archive.php?iMenuID=63&iYear=2007
Item Type: | HTA Newsletter Item |
---|---|
Keywords: | Children, Turner syndrome, disturbance of growth, fetal growth retardation, intrauterine growth retardation (IUGR), Prader-Willi syndrome (PWS), recombinant growth hormone (GH), somatotropin, benefits, risks |
Subjects: | WS Pediatrics WK Endocrine system > WK 150-190 Hormones. Hormone therapy |
Related URLs: | http://hta.lbg.ac.at/en/content.php?iMenuID=40 |
References: | 1. Perry, JK et al. 2006: The oncogenic potential of growth hormone. Growth hormone & IGF Research. 277-289. 2. AHRQ/USA 2003: Criteria for determining disability in infants and children: short stature. URL: http://www.ahrq.gov/clinic/epcsums/shortsum.htm. 3. ScHARR/GB 2002: Clinical and cost-effectiveness of recombinant human growth hormone(somatropin) in adults. URL: http://www.nice.org.uk/pdf/GHDscharrreport.pdf. |
Language: | German |
Number: | 54 |
Deposited on: | 18 Jan 2008 11:54 |
Last Modified: | 15 Jul 2020 17:19 |
Repository Staff Only: item control page